<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: Successful ", fill: "#002fa7"},
{source: "2: Successful ", target: "2: integration", fill: "#002fa7"},
{source: "2: integration", target: "2: Company OptiCare and US Vision ", fill: "#002fa7"},
{source: "2: Company OptiCare and US Vision ", target: "2: things implementing", fill: "#002fa7"},
{source: "2: Successful ", target: "3: managements attention", fill: "#80461b"},
{source: "3: managements attention", target: "3: integration effort", fill: "#80461b"},
{source: "3: integration effort", target: "3: difficulty encountered", fill: "#80461b"},
{source: "3: difficulty encountered", target: "3: coordinating operations could", fill: "#80461b"},
{source: "3: coordinating operations could", target: "3: interruption", fill: "#80461b"},
{source: "3: interruption", target: "3: activities", fill: "#80461b"},
{source: "3: activities", target: "3: companies businesses", fill: "#80461b"},
{source: "3: managements attention", target: "5: OptiCares and US Visions ", fill: "#ff6fff"},
{source: "5: OptiCares and US Visions ", target: "5: current contracts", fill: "#ff6fff"},
{source: "5: current contracts", target: "5: relationships", fill: "#ff6fff"},
{source: "5: OptiCares and US Visions ", target: "8: acquisition", fill: "#673147"},
{source: "8: acquisition", target: "8: dominant optical retailer", fill: "#673147"},
{source: "8: dominant optical retailer", target: "8: United States ", fill: "#673147"},
{source: "8: United States ", target: "8: competitors", fill: "#673147"},
{source: "8: acquisition", target: "12: compete with", fill: "#ffc40c"},
{source: "12: compete with", target: "12: businesses", fill: "#ffc40c"},
{source: "12: businesses", target: "12: eye care services companies hospitals", fill: "#ffc40c"},
{source: "12: eye care services companies hospitals", target: "12: ophthalmology", fill: "#ffc40c"},
{source: "12: ophthalmology", target: "12: optometry practices", fill: "#ffc40c"},
{source: "12: optometry practices", target: "12: ambulatory surgery", fill: "#ffc40c"},
{source: "12: ambulatory surgery", target: "12: retail optical products", fill: "#ffc40c"},
{source: "12: compete with", target: "13: Companies ", fill: "#a52a2a"},
{source: "13: Companies ", target: "13: specialties", fill: "#a52a2a"},
{source: "13: specialties", target: "13: medical practices may become competitors", fill: "#a52a2a"},
{source: "13: medical practices may become competitors", target: "13: providing surgery", fill: "#a52a2a"},
{source: "13: Companies ", target: "14: compete effectively with", fill: "#a9a9a9"},
{source: "14: compete effectively with", target: "14: competitors", fill: "#a9a9a9"},
{source: "14: competitors", target: "14: financial condition", fill: "#a9a9a9"},
{source: "14: financial condition", target: "14: operations", fill: "#a9a9a9"},
{source: "14: compete effectively with", target: "18: US Visions Business ", fill: "#900"},
{source: "18: US Visions Business ", target: "18: Materially Dependent Upon the Revenues ", fill: "#900"},
{source: "18: Materially Dependent Upon the Revenues ", target: "18: Participating Provider ", fill: "#900"},
{source: "18: Participating Provider ", target: "18: Agreement ", fill: "#900"},
{source: "18: Agreement ", target: "18: materially dependent upon", fill: "#900"},
{source: "18: materially dependent upon", target: "18: derives as", fill: "#900"},
{source: "18: derives as", target: "18: participating provider through", fill: "#900"},
{source: "18: participating provider through", target: "18: fiscal year", fill: "#900"},
{source: "18: US Visions Business ", target: "19: organization", fill: "#3c341f"},
{source: "19: organization", target: "19: integrating", fill: "#3c341f"},
{source: "19: integrating", target: "19: operations", fill: "#3c341f"},
{source: "19: operations", target: "19: of EyeMed Vision Care and CMV US Visions ", fill: "#3c341f"},
{source: "19: of EyeMed Vision Care and CMV US Visions ", target: "19: participating provider agreement with", fill: "#3c341f"},
{source: "19: participating provider agreement with", target: "19: expires on", fill: "#3c341f"},
{source: "19: expires on", target: "19: December ", fill: "#3c341f"},
{source: "19: organization", target: "21: seeking various agreements", fill: "#2a8000"},
{source: "21: seeking various agreements", target: "21: studying various alternatives", fill: "#2a8000"},
{source: "21: studying various alternatives", target: "21: such termination on", fill: "#2a8000"},
{source: "21: seeking various agreements", target: "26: licensor requirements associated with", fill: "#013220"},
{source: "26: licensor requirements associated with", target: "26: managed care", fill: "#013220"},
{source: "26: managed care", target: "26: civil false", fill: "#013220"},
{source: "26: civil false", target: "26: corporate practice", fill: "#013220"},
{source: "26: corporate practice", target: "26: medicine restrictions", fill: "#013220"},
{source: "26: medicine restrictions", target: "26: facility license requirements", fill: "#013220"},
{source: "26: facility license requirements", target: "26: certificates", fill: "#013220"},
{source: "26: certificates", target: "26: medical devices", fill: "#013220"},
{source: "26: medical devices", target: "26: laser vision correction", fill: "#013220"},
{source: "26: laser vision correction", target: "26: refractive surgery procedures", fill: "#013220"},
{source: "26: refractive surgery procedures", target: "26: FDA and FTC ", fill: "#013220"},
{source: "26: FDA and FTC ", target: "26: guidelines", fill: "#013220"},
{source: "26: guidelines", target: "26: marketing laser vision correction", fill: "#013220"},
{source: "26: marketing laser vision correction", target: "26: personally identifiable health", fill: "#013220"},
{source: "26: licensor requirements associated with", target: "48: potential conflicts", fill: "#746cc0"},
{source: "48: potential conflicts", target: "48: opportunities potential acquisitions", fill: "#746cc0"},
{source: "48: opportunities potential acquisitions", target: "48: financing transactions sales", fill: "#746cc0"},
{source: "48: financing transactions sales", target: "48: dispositions by", fill: "#746cc0"},
{source: "48: dispositions by", target: "48: exercise by", fill: "#746cc0"},
{source: "48: exercise by", target: "48: management", fill: "#746cc0"},
{source: "48: potential conflicts", target: "74: Connecticut ", fill: "#ffa812"},
{source: "74: Connecticut ", target: "74: OptiCares ", fill: "#ffa812"},
{source: "74: OptiCares ", target: "74: OptiCare Eye Health Centers Inc ", fill: "#ffa812"},
{source: "74: OptiCare Eye Health Centers Inc ", target: "74: professional corporation", fill: "#ffa812"},
{source: "74: Connecticut ", target: "95: relationship with", fill: "#c80815"},
{source: "95: relationship with", target: "95: JC Penney ", fill: "#c80815"},
{source: "95: JC Penney ", target: "95: termination", fill: "#c80815"},
{source: "95: termination", target: "95: optical center leases would", fill: "#c80815"},
{source: "95: optical center leases would", target: "95: financial condition", fill: "#c80815"},
{source: "95: financial condition", target: "95: operations", fill: "#c80815"},
{source: "95: relationship with", target: "START_HERE", fill: "#c80815"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Housewares and Specialties</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Human Resource and Employment Services</td>
    </tr>
    <tr>
      <td>Commercial and Professional Services</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Independent Power Producers and Energy Traders</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Material Aid</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Formally complain</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Propose</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Consult</td>
    </tr>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Vote</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Vertical_integration">Vertical integration</a></td>
      <td>In microeconomics, management, and international political economy, vertical integration is an arrangement in which the supply chain of a company is integrated and owned by that company. Usually each member of the supply chain produces a different product or (market-specific) service, and the products combine to satisfy a common need.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Integrator">Integrator</a></td>
      <td>An integrator in measurement and control applications is an element whose output signal is the time integral of its input signal. It accumulates the input quantity over a defined time to produce a representative output.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Continuous_integration">Continuous integration</a></td>
      <td>In software engineering, continuous integration (CI) is the practice of merging all developers' working copies to a shared mainline several times a day. Grady Booch first proposed the term CI in his 1991 method, although he did not advocate integrating several times a day.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Extracurricular_activity">Extracurricular activity</a></td>
      <td>An extracurricular activity (ECA) or extra academic activity (EAA) or cultural activities is an activity, performed by students, that falls outside the realm of the normal curriculum of school, college or university education. Such activities are generally voluntary (as opposed to mandatory), social, philanthropic, and often involve others of the same age.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Activity_diagram">Activity diagram</a></td>
      <td>Activity diagrams are graphical  representations of workflows of stepwise activities and actions with support for choice, iteration and concurrency. In the Unified Modeling Language, activity diagrams are intended to model both computational and organizational processes (i.e., workflows), as well as the data flows intersecting with the related activities.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Student_activities">Student activities</a></td>
      <td>Student activities (also known as campus activities) are student-focused extracurricular clubs and programs offered at a college or university. Student activities are generally designed to allow students to become more involved on campus.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Open_relationship">Open relationship</a></td>
      <td>An open relationship is an intimate relationship that is sexually non-monogamous. The term is distinct from polyamory, in that it generally indicates a relationship where there is a primary emotional and intimate relationship between two partners, who agree to at least the possibility of sexual or emotional intimacy with other people.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Customer_relationship_management">Customer relationship management</a></td>
      <td>Customer relationship management (CRM) is a process in which a business or other organization administers its interactions with customers, typically using data analysis to study large amounts of information.CRM systems compile data from a range of different communication channels, including a company's website, telephone, email, live chat, marketing materials and more recently, social media. They allow businesses to learn more about their target audiences and how to best cater for their needs, thus retaining customers and driving sales growth.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Entity–relationship_model">Entity–relationship model</a></td>
      <td>An entity–relationship model (or ER model) describes interrelated things of interest in a specific domain of knowledge. A basic ER model is composed of entity types (which classify the things of interest) and specifies relationships that can exist between entities (instances of those entity types).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitor_analysis">Competitor analysis</a></td>
      <td>Competitive analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors. This analysis provides both an offensive and defensive strategic context to identify opportunities and threats.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Competitors_for_the_Crown_of_Scotland">Competitors for the Crown of Scotland</a></td>
      <td>When the crown of Scotland became vacant in September 1290 on the death of the seven-year-old child Queen Margaret, 13 claimants to the throne came forward. Those with the most credible claims were John Balliol, Robert Bruce, John Hastings and Floris V, Count of Holland.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Sport_of_athletics">Sport of athletics</a></td>
      <td>Athletics is a group of sporting events that involves competitive running, jumping, throwing, and walking. The most common types of athletics competitions are track and field, road running, cross country running, and racewalking.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/List_of_Dancing_with_the_Stars_(American_TV_series)_competitors">List of Dancing with the Stars (American TV series) competitors</a></td>
      <td>Dancing with the Stars is an American reality television show in which celebrity contestants and professional dance partners compete to be the best dancers, as determined by the show's judges and public voting. The series first broadcast in 2005, and thirty complete seasons have aired on ABC. During each season, competitors are progressively eliminated on the basis of public voting and scores received from the judges until only a few contestants remain.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Ophthalmology">Ophthalmology</a></td>
      <td>Ophthalmology () is a branch of medicine that deals with the diagnosis and treatment of eye disorders. An ophthalmologist is a physician who specializes in eye care.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Couching_(ophthalmology)">Couching (ophthalmology)</a></td>
      <td>Couching is the earliest documented form of cataract surgery.  As a cataract is a clouding in the lens of the eye, couching is a technique whereby the lens is dislodged, thus removing the opacity.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Regional_Institute_of_Ophthalmology,_Thiruvananthapuram">Regional Institute of Ophthalmology, Thiruvananthapuram</a></td>
      <td>The Regional Institute of Ophthalmology, Thiruvananthapuram is the highest government level referral hospital in the field of ophthalmology in Kerala state. As of 2021, it is the only Regional Institute of Ophthalmology in Kerala.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Tilganga_Institute_of_Ophthalmology">Tilganga Institute of Ophthalmology</a></td>
      <td>Tilganga Institute of Ophthalmology, formerly called the Tilganga Eye Centre, in Nepal is the implementing body of the Nepal Eye Program, a non-profit, community based, non-government organization launched in 1992. It was founded in part by renowned ophthalmologist and cataract surgeon Sanduk Ruit.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Heterochromia_iridum">Heterochromia iridum</a></td>
      <td>Heterochromia is a variation in coloration. The term is most often used to describe color differences of the iris, but can also be applied to color variation of hair or skin.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Myopia">Myopia</a></td>
      <td>Myopia, also known as near-sightedness and short-sightedness, is an eye disorder where light focuses in front of, instead of on, the retina. As a result, distant objects appear blurry while close objects appear normal.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Managed_care">Managed care</a></td>
      <td>The term managed care or managed healthcare is used in the United States to describe a group of activities intended to reduce the cost of providing health care and providing American health insurance while improving the quality of that care ("managed care techniques").  It has become the predominant system of delivering and receiving American health care since its implementation in the early 1980s, and has been largely unaffected by the Affordable Care Act of 2010.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_condition_report">Financial condition report</a></td>
      <td>In accounting, a financial condition report (FCR) is a report on the solvency condition of an insurance company that takes into account both the current financial status, as reflected in the balance sheet, and an assessment of the ability of the company to survive future risk scenarios. Risk assessment in an FCR involves dynamic solvency testing, a type of dynamic financial analysis that simulates management response to risk scenarios, to test whether a company could remain solvent in the face of deteriorating economic conditions or major disasters.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_statement">Financial statement</a></td>
      <td>Financial statements (or financial reports) are formal records of the financial activities and position of a business, person, or other entity.\nRelevant financial information is presented in a structured manner and in a form which is easy to understand.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_law">Financial law</a></td>
      <td>Financial law is the law and regulation of the insurance, derivatives, commercial banking, capital markets and investment management sectors. Understanding Financial law is crucial to appreciating the creation and formation of banking and financial regulation, as well as the legal framework for finance generally.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Trustmark_(bank)">Trustmark (bank)</a></td>
      <td>Trustmark is a commercial bank and financial services company headquartered in Jackson, Mississippi, United States, with subsidiaries Trustmark National Bank, Trustmark Investment Advisors, and Fisher Brown Bottrell Insurance. The bank's initial predecessor, The Jackson Bank, was chartered by the State of Mississippi in 1889.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Operations_research">Operations research</a></td>
      <td>Operations research (British English: operational research), often shortened to the initialism OR, is a discipline that deals with the development and application of advanced analytical methods to improve decision-making. It is sometimes considered to be a subfield of mathematical sciences.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/TRIPS_Agreement">TRIPS Agreement</a></td>
      <td>The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is an international legal agreement between all the member nations of the World Trade Organization (WTO). It establishes minimum standards for the regulation by national governments of different forms of intellectual property (IP) as applied to nationals of other WTO member nations.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_1">December 1</a></td>
      <td>December is the twelfth and the final month of the year in the Julian and Gregorian calendars. It is also the last of seven months to have a length of 31 days.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/December_12">December 12</a></td>
      <td>December 12 is the 346th day of the year (347th in leap years) in the Gregorian calendar;  19 days remain until the end of the year.\n\n\n== Events ==\n\n\n=== Pre-1600 ===\n627 – Battle of Nineveh: A Byzantine army under Emperor Heraclius defeats Emperor Khosrau II's Persian forces, commanded by General Rhahzadh.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Termination_of_employment">Termination of employment</a></td>
      <td>Termination of employment or separation of employment is an employee's departure from a job and the end of an employee's duration with an employer. Termination may be voluntary on the employee's part, or it may be at the hands of the employer, often in the form of dismissal (firing) or a layoff.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Abbott_Laboratories">Abbott Laboratories</a></td>
      <td>Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Test_management">Test management</a></td>
      <td>Test management most commonly refers to the activity of managing a testing process. A test management tool is software used to manage tests (automated or manual) that have been previously specified by a test procedure.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/École_secondaire_catholique_Béatrice-Desloges">École secondaire catholique Béatrice-Desloges</a></td>
      <td>École secondaire catholique Béatrice-Desloges (ESCBD, Béatrice-Desloges Catholic High School) is a French language high school  in the community of Orléans, in the eastern part of Ottawa, Ontario, Canada. The school also houses a community child day care centre, and is currently the largest or second largest and most populated French high school in Ontario, either surpassing or coming very close to that of the Thériault Catholic High School located in Timmins.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Network_termination">Network termination</a></td>
      <td>A network termination (NT) (also NTE for network termination equipment) is a device that connects the customer's data or telephone equipment to a carrier's line that comes into a building or an office. The NT device provides a connection for terminal equipment (TE) and terminal adapter (TA) equipment to the local loop.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>REFAC OPTICAL GROUP      Item 1A     Risk Factors       <font color="blue">Successful </font>Integration will be Complex and Time-Consuming</td>
    </tr>
    <tr>
      <td><font color="blue">Successful </font><font color="blue">integration</font> of the Company, OptiCare and US Vision will     require, among other things, implementing a strategic plan for the combined     companies</td>
    </tr>
    <tr>
      <td>We may not accomplish this <font color="blue">integration</font> <font color="blue">successfully</font> and any     diversion  of <font color="blue">management</font>’s attention to the <font color="blue">integration</font> effort and any     <font color="blue"><font color="blue">difficulty</font> encountered</font> in combining or <font color="blue">coordinating <font color="blue">operations</font> could</font> cause     the <font color="blue">interruption</font> of, or a loss of momentum in, the <font color="blue">activities</font> of any or all     of the companies’ <font color="blue">businesses</font></td>
    </tr>
    <tr>
      <td>Furthermore, <font color="blue">employee morale may suffer</font>, and     we may have <font color="blue">difficulty</font> retaining <font color="blue">key personnel</font></td>
    </tr>
    <tr>
      <td>There is no assurance that     we will be able to maintain or renew all of OptiCare’s and US Vision’s     <font color="blue">current contracts</font> and <font color="blue">relationships</font></td>
    </tr>
    <tr>
      <td>We May not be able to <font color="blue">Compete Effectively </font>with <font color="blue">Other Eye Care Distributors     </font>and  Other  Eye  Care Services <font color="blue">Companies </font>which <font color="blue">Have More Resources </font>and     <font color="blue">Experience </font>than us</td>
    </tr>
    <tr>
      <td>On October 4, 2004, Luxottica, the parent of LensCrafters and the     world leader in the design, manufacture and <font color="blue">distribution</font> of <font color="blue">prescription</font>     frames and sunglasses in the mid- and premium-price categories, acquired     Cole National, a leading optical retailer which also operates CMV, a major     national vision program</td>
    </tr>
    <tr>
      <td>Prior to this <font color="blue">acquisition</font>, Luxottica was already     the <font color="blue">dominant optical retailer</font> in the <font color="blue"><font color="blue">United States</font> </font>with more sales and     resources  than  its  <font color="blue">competitors</font></td>
    </tr>
    <tr>
      <td>Its  <font color="blue">acquisition</font>  of <font color="blue">Cole National </font>    <font color="blue">substantially lessens</font> the ability of <font color="blue"><font color="blue">retail optical</font> companies</font>, including us     as a result of the mergers, to <font color="blue"><font color="blue">successfully</font> <font color="blue">compete with</font></font> it</td>
    </tr>
    <tr>
      <td>In addition, some companies in the <font color="blue">retail optical</font> business have     substantially <font color="blue">greater financial</font>, technical, managerial, marketing and other     resources and experience than we do</td>
    </tr>
    <tr>
      <td>As a result, these other companies may     compete more <font color="blue">effectively</font> than us and our <font color="blue">subsidiaries</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">compete with</font> other     <font color="blue">businesses</font>,  including  other  eye care services companies, hospitals,     individual <font color="blue">ophthalmology</font> and <font color="blue">optometry practices</font>, other <font color="blue">ambulatory surgery</font>     and  laser <font color="blue">vision correction</font> centers, <font color="blue">managed care</font> companies, eye care     clinics and providers of <font color="blue">retail optical</font> products</td>
    </tr>
    <tr>
      <td><font color="blue">Companies </font>in other health     care  industry  segments, including managers of hospital-based medical     <font color="blue">specialties</font> or large group medical practices, may become <font color="blue">competitors</font> in     <font color="blue">providing surgery</font> and laser centers, as well as competitive eye care-related     services</td>
    </tr>
    <tr>
      <td>The failure to compete <font color="blue">effectively</font> with these and other <font color="blue">competitors</font>     could have a material adverse effect on our business, <font color="blue">financial condition</font>     and  results  of  <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>The  <font color="blue">retail optical</font> industry engages in     price-related  promotions  as  a  standard <font color="blue">marketing practice</font></td>
    </tr>
    <tr>
      <td><font color="blue">Several     </font><font color="blue">competitors</font> have <font color="blue">greater financial</font> and other <font color="blue">resources than</font> we do, which may     enable such <font color="blue">competitors</font> to pursue more <font color="blue">aggressive pricing</font> and promotional     <font color="blue">strategies at</font> the expense of profits for <font color="blue">longer periods</font> of time than we can</td>
    </tr>
    <tr>
      <td>We also face the <font color="blue">possibility</font> of a <font color="blue">decreased demand</font> for <font color="blue">eyeglasses</font> and     <font color="blue">contact lenses as advances</font> in, and the <font color="blue">acceptability</font> of, <font color="blue">vision correction</font>     <font color="blue">technologies</font>, including <font color="blue">laser surgery</font> and other surgical <font color="blue">vision correction</font>     procedures, continue to grow</td>
    </tr>
    <tr>
      <td>US Vision’s Business is <font color="blue"><font color="blue">Materially Dependent </font>Upon the Revenues </font>that it     Derives as a <font color="blue">Participating Provider </font>under its <font color="blue">Agreement </font>with CMV             US Vision’s business is <font color="blue"><font color="blue">materially</font> dependent upon</font> the revenues that     it <font color="blue">derives as</font> a <font color="blue">participating provider through</font> CMV This business accounted     for approximately 22prca of US Vision’s revenue for the <font color="blue">fiscal year</font> ended     January 31, 2006</td>
    </tr>
    <tr>
      <td>Luxottica, which owns CMV and also owns EyeMed Vision     Care, a leading managed vision care <font color="blue">organization</font>, recently announced that it     was <font color="blue">integrating</font> the <font color="blue">operations</font> of <font color="blue">EyeMed Vision Care</font> and CMV US Vision’s     <font color="blue">participating provider <font color="blue">agreement</font> with</font> CMV <font color="blue">expires on</font> <font color="blue">December </font>31, 2008</td>
    </tr>
    <tr>
      <td>As a     result of this <font color="blue">integration</font>, it appears unlikely that US Vision will be     able to renew or extend its <font color="blue">agreement</font> with CMV or <font color="blue">enter into</font> a comparable     <font color="blue">agreement</font> with <font color="blue">EyeMed Vision Care</font></td>
    </tr>
    <tr>
      <td>We are seeking various <font color="blue">agreement</font>s and     <font color="blue">studying various <font color="blue">alternatives</font></font> to minimize the effect of <font color="blue">such <font color="blue">termination</font> on</font>     our business</td>
    </tr>
    <tr>
      <td>However no assurance can be given that we will be able to     <font color="blue">enter into</font> other <font color="blue">agreement</font>s or find suitable <font color="blue">alternatives</font></td>
    </tr>
    <tr>
      <td>If we are not     able to do so and the CMV <font color="blue">agreement</font> is terminated, there will likely be a     material  adverse  <font color="blue">impact on</font> our business, <font color="blue">operations</font> and/or financial     condition</td>
    </tr>
    <tr>
      <td>The <font color="blue">businesses</font> is currently subject to extensive federal and state     <font color="blue">governmental regulation</font> and <font color="blue">supervision</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">regulations</font> include, but are     not limited to:         •  anti-kickback statutes;         •  self-referral laws;         •  insurance and <font color="blue">licensor <font color="blue">requirements</font> associated with</font> the <font color="blue">managed care</font>     business;         •  <font color="blue">civil false</font> claims acts;         •  <font color="blue">corporate practice</font> of <font color="blue">medicine restrictions</font>;         •  fee-splitting laws;         •  <font color="blue"><font color="blue">facility</font> license <font color="blue">requirements</font></font> and <font color="blue">certificates</font> of need;         •  regulation of <font color="blue">medical devices</font>, including laser <font color="blue">vision correction</font> and     other <font color="blue">refractive surgery procedures</font>;         •  <font color="blue">FDA and FTC </font><font color="blue">guidelines</font> for marketing laser <font color="blue">vision correction</font>; and         •  regulation of <font color="blue">personally identifiable health</font> information</td>
    </tr>
    <tr>
      <td>We have no assurance that these laws and <font color="blue"><font color="blue">regulations</font> will</font> not change     or be interpreted in the <font color="blue">future either</font> to restrict or <font color="blue"><font color="blue">adversely</font> affect</font> its     business <font color="blue">activities</font></td>
    </tr>
    <tr>
      <td>The  health  care  industry has experienced a <font color="blue">trend toward cost</font>     <font color="blue">containment as government</font> and private third-party payers seek to impose     <font color="blue">lower reimbursement</font> and <font color="blue"><font color="blue">utilization</font> rates</font> and <font color="blue">negotiate reduced payment</font>     schedules  with  service  providers</td>
    </tr>
    <tr>
      <td>Our  revenues will be subject to     pre-determined  Medicare  <font color="blue">reimbursement rates</font> for <font color="blue">certain products</font> and     services,  and <font color="blue">decreases</font> in Medicare <font color="blue">reimbursement rates</font> could have an     adverse  effect on our results of <font color="blue">operations</font> if we <font color="blue">cannot offset</font> these     <font color="blue">reductions through increases</font> in revenues or <font color="blue">decreases</font> in operating costs</td>
    </tr>
    <tr>
      <td>To     some degree, prices for <font color="blue">health care services</font> and products are <font color="blue">driven by</font>     Medicare <font color="blue">reimbursement rates</font>, so that non-Medicare business is <font color="blue">also affected</font>     by changes in Medicare <font color="blue">reimbursement rates</font></td>
    </tr>
    <tr>
      <td>In addition, federal and state     <font color="blue">governments</font>  are  currently  considering  <font color="blue">various types</font> of health care     <font color="blue">initiatives</font>  and <font color="blue">comprehensive revisions</font> to the health care and health     <font color="blue">insurance systems</font></td>
    </tr>
    <tr>
      <td>Some of the <font color="blue">proposals under consideration</font>, or others that     may be introduced, could, if adopted, have a material adverse effect on our     business,  <font color="blue">financial condition</font> and results of <font color="blue">operations</font> following the     mergers</td>
    </tr>
    <tr>
      <td>Risks Related to the Eye Care Industry, Including the Cost and Availability     of Medical Malpractice Insurance, and Possible Adverse Long-Term <font color="blue">Experience </font>    With  Laser and Other Surgical Vision Correction Could Have a Material     Adverse  Effect  on  Our  Business, Financial Condition and Results of     Operations             The provision of <font color="blue">eye care services entails</font> the potentially significant     risk  of <font color="blue">physical injury</font> to patients and an <font color="blue">inherent risk</font> of potential     malpractice, product liability and other similar claims</td>
    </tr>
    <tr>
      <td>Insurance may not     be  adequate to satisfy claims or protect the <font color="blue">combined company</font> and its     <font color="blue">affiliated eye care providers</font>, and this <font color="blue">coverage may</font> not continue to be     <font color="blue">available at</font> acceptable costs</td>
    </tr>
    <tr>
      <td>A partially or <font color="blue">completely uninsured</font> claim     <font color="blue">against us</font> or our <font color="blue">subsidiaries</font> following the <font color="blue">mergers could</font> have a material     adverse  effect  on  the  business, <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Several large national <font color="blue">managed care</font> companies have been the target of     class <font color="blue">action lawsuits</font> alleging <font color="blue">fraudulent practices</font> in the <font color="blue">de<font color="blue">termination</font></font> of     <font color="blue">health care coverage policies</font> for their <font color="blue">beneficiaries</font></td>
    </tr>
    <tr>
      <td>Such lawsuits have,     thus far, <font color="blue">been aimed solely at</font> full service <font color="blue">managed care</font> plans and not     companies that specialize in specific segments, such as eye care</td>
    </tr>
    <tr>
      <td>We cannot     assure you that <font color="blue">private party litigation</font>, including class action suits, will     not <font color="blue">target eye care</font> in the future, or that the <font color="blue">combined company</font> will not     otherwise be <font color="blue">affected by such litigation following</font> the mergers</td>
    </tr>
    <tr>
      <td>Loss of the Services of Key Management Personnel Could Adversely Affect the     Company’s Business</td>
    </tr>
    <tr>
      <td>The <font color="blue">successful completion</font> of the mergers and <font color="blue">integration</font> of <font color="blue">OptiCare  </font>   and US Vision <font color="blue">depends upon</font> the <font color="blue">continued services</font> of <font color="blue">certain executive</font>     officers of the Company, OptiCare and US Vision</td>
    </tr>
    <tr>
      <td>We believe that the loss     of  certain of <font color="blue">such executive officers during</font> this <font color="blue">period could</font> have a     material adverse effect on our business, <font color="blue">financial condition</font> and results of     <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>Palisade currently owns approximately 88prca of our <font color="blue">common stock</font> and     therefore will determine the outcome of all <font color="blue">corporate matters</font> requiring     <font color="blue">stockholder approval</font>, including the election of all of our <font color="blue">directors</font> and     material <font color="blue">transactions</font></td>
    </tr>
    <tr>
      <td><font color="blue">Conflicts </font>of interest may arise between us and Palisade and its     <font color="blue">affiliates</font> in areas relating to past, ongoing and future <font color="blue">relationships</font> and     other matters</td>
    </tr>
    <tr>
      <td>These <font color="blue">potential conflicts</font> of interest include corporate     opportunities, potential <font color="blue">acquisition</font>s or financing <font color="blue">transactions</font>, sales or     other <font color="blue">dispositions by</font> Palisade of the shares of our stock held by it, and     the  <font color="blue">exercise by</font> Palisade of its ability to control our <font color="blue">management</font> and     affairs</td>
    </tr>
    <tr>
      <td>In <font color="blue">addition one</font> of our <font color="blue">directors</font> is an officer of PCM and a member     of Holdings, both of which are <font color="blue">affiliates</font> of Palisade</td>
    </tr>
    <tr>
      <td>There can be no     assurance that any conflicts that may arise between Palisade and us that     will not have a material adverse effect on our business, <font color="blue">financial condition</font>     and results of <font color="blue">operations</font> or our other <font color="blue">stockholders</font></td>
    </tr>
    <tr>
      <td>In <font color="blue"><font color="blue">connection</font> with</font> the formation of a <font color="blue">new <font color="blue">private equity</font> partnership</font>,     PCM  intends  to  <font color="blue">consult with</font> a group of senior experienced operating     <font color="blue">executives</font>  to  assist it in the screening and selection of <font color="blue">investment</font>     <font color="blue">opportunities as well as ongoing monitoring</font> and <font color="blue">management</font> of portfolio     companies</td>
    </tr>
    <tr>
      <td>Included in this group are Eugene K Bolton, a director; Clark A     Johnson,  a director and an owner of a 5prca preferred, non-voting equity     interest in PCM; Melvin Meskin, a director; Mark S Newman, a director; and     Jeffrey D Serkes, a director</td>
    </tr>
    <tr>
      <td>In <font color="blue">most instances</font>, it is expected that these     <font color="blue">persons would</font> be <font color="blue">compensated directly by</font> the <font color="blue">portfolio companies</font></td>
    </tr>
    <tr>
      <td>Pursuant to <font color="blue">employment</font> <font color="blue">agreement</font>s entered into on April 1, 2005, each     of  Robert L Tuchman, the Company’s Senior Vice President and General     Counsel,  and  Raymond A Cardonne, Jr, the Company’s Chief Financial     Officer, <font color="blue">may <font color="blue">enter into</font> separate arrangements</font> for his own <font color="blue">account with</font> PCM     and/or any of its <font color="blue">affiliated companies</font> that are engaged in <font color="blue">private equity</font> or     <font color="blue">investment</font> <font color="blue">management</font> pursuant to which he may become a member, partner,     officer, director or stockholder of such entity or <font color="blue">may provide consulting</font> or     <font color="blue">professional</font>  services  thereto  provided  that such <font color="blue">activities</font> do not     <font color="blue">materially</font>  interfere  with  the <font color="blue">regular performance</font> of his duties and     <font color="blue"><font color="blue">responsibilities</font> under</font> his respective <font color="blue">employment</font> <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>Tuchman     and Cardonne also have interests in the <font color="blue">general partner</font> of a <font color="blue">private equity</font>     <font color="blue">partnership recently formed by</font> <font color="blue">PCM                                         </font>17       _________________________________________________________________    [64]Table of Contents       OptiCare and US Vision Have Not Had Profitable Operations in Recent Years,     and We Cannot Assure that the Company will be Profitable</td>
    </tr>
    <tr>
      <td>In <font color="blue">recent years</font>, OptiCare’s and US Vision’s <font color="blue">operations</font> have not been     profitable</td>
    </tr>
    <tr>
      <td>OptiCare had net losses of dlra12dtta3 million and dlra8dtta3 million for     the years ended <font color="blue">December </font>31, 2003 and <font color="blue">December </font>31, 2004, respectively</td>
    </tr>
    <tr>
      <td>We <font color="blue">cannot assure</font> that     efforts to improve <font color="blue">profitability</font> through, among other things, economies of     scale and cost-efficiencies, will be successful or that the <font color="blue">combined company</font>     will be <font color="blue">profitable following</font> the mergers</td>
    </tr>
    <tr>
      <td>We intend to expand our <font color="blue">operations</font> through organic growth, strategic     <font color="blue">acquisition</font>s and/or other business combination <font color="blue">transactions</font> in the eye care     industry</td>
    </tr>
    <tr>
      <td>We believe that OptiCare can become the <font color="blue">largest optical retailer</font>     in the <font color="blue">State of <font color="blue">Connecticut</font></font> by acquiring <font color="blue"><font color="blue">additional</font> locations</font> in existing     markets to fill in <font color="blue">excess capacity as well as</font> in <font color="blue">new markets within</font> the     <font color="blue">State of <font color="blue">Connecticut</font></font></td>
    </tr>
    <tr>
      <td>US Vision is <font color="blue">already one</font> of the leading store-within-a-store optical     retailers in the <font color="blue">United States</font></td>
    </tr>
    <tr>
      <td>Refac believes that there is <font color="blue">opportunity</font> for     US Vision to increase the number of stores within the existing host stores     in which it operates as well as open new host store <font color="blue">relationships</font></td>
    </tr>
    <tr>
      <td>We also     intend to explore the <font color="blue">possibility</font> of acquiring one or more <font color="blue">free standing</font>     optical  chains  that <font color="blue">might become available</font> for sale</td>
    </tr>
    <tr>
      <td>There can be no     assurance that any or all of these growth <font color="blue">initiatives</font> will prove to be     profitable</td>
    </tr>
    <tr>
      <td>Additionally, the growth strategy of the <font color="blue">combined company</font> depends in     part on its ability to expand and <font color="blue">successfully</font> implement an integrated     business model</td>
    </tr>
    <tr>
      <td>We expect that this <font color="blue">growth strategy will</font> result in increased     <font color="blue">responsibilities</font>  for <font color="blue">management</font> and <font color="blue">additional</font> demands on <font color="blue">management</font>,     operating  and <font color="blue">financial systems</font> and resources</td>
    </tr>
    <tr>
      <td>The <font color="blue">combined company</font>’s     ability  to <font color="blue">expand will also depend upon</font> its ability to hire and train     <font color="blue"><font color="blue">additional</font> staff</font> and <font color="blue">managerial personnel</font>, and adapt, as necessary, its     structure to <font color="blue"><font color="blue">comply with</font> present</font> or <font color="blue">future legal <font color="blue">requirements</font> affecting</font>     <font color="blue">arrangements with ophthalmologists</font> and <font color="blue">optometrists</font></td>
    </tr>
    <tr>
      <td>If we are unable to make strategic <font color="blue">acquisition</font>s in the eye care     industry and implement its <font color="blue">internal growth strategy following</font> the mergers,     its business, <font color="blue">financial condition</font>, results of <font color="blue">operations</font> and ability to     achieve and <font color="blue">sustain <font color="blue">profitability</font> could</font> be <font color="blue">materially</font> <font color="blue"><font color="blue">adversely</font> affect</font>ed</td>
    </tr>
    <tr>
      <td>OptiCare’s Business is <font color="blue">Substantially Dependent </font>on a Professional Services     and Support <font color="blue">Agreement </font>with a <font color="blue">Professional Affiliate</font></td>
    </tr>
    <tr>
      <td>The laws of the <font color="blue">State of <font color="blue">Connecticut</font></font> (in which OptiCare conducts all     of its <font color="blue">operations</font>) as well as some other states <font color="blue">prohibit corporations</font> that     are not owned entirely by eye care <font color="blue">professional</font>s from (i) <font color="blue">employing eye care</font>     <font color="blue">professional</font>s, (ii) receiving for their own <font color="blue">account reimbursements from</font>     third-party  payers  for  health  care  services  rendered by licensed     <font color="blue">professional</font>s; (iii) controlling clinical decision-making; or (iv) engaging     in  other  <font color="blue">activities</font> that <font color="blue">constitute</font> the practice of <font color="blue">ophthalmology</font> or     optometry</td>
    </tr>
    <tr>
      <td>To  comply  with  <font color="blue"><font color="blue">Connecticut</font> </font>law, OptiCare’s wholly-owned     subsidiary, OptiCare Eye Health Centers, Inc, is party to a Professional     Services  and  Support  <font color="blue">Agreement </font> with  OptiCare, PC, a <font color="blue"><font color="blue">Connecticut</font> </font>    <font color="blue">professional</font> corporation, of which Dr</td>
    </tr>
    <tr>
      <td>Yimoyines, the current <font color="blue">Chairman </font>and     Interim Chief Executive Officer of OptiCare, is the <font color="blue">sole stockholder</font></td>
    </tr>
    <tr>
      <td><font color="blue">Under     </font>this <font color="blue">agreement</font>, OptiCare, PC <font color="blue">employs medical personnel</font> and performs all     <font color="blue">ophthalmology</font>  and  optometry  services  at  OptiCare’s  <font color="blue">facilities</font> in     <font color="blue">Connecticut</font></td>
    </tr>
    <tr>
      <td><font color="blue">Conflicts </font> of  interests  may also arise in <font color="blue"><font color="blue">connection</font> with</font> the     Professional Services and Support Agreement, because Dean J Yimoyines, the     <font color="blue">Chairman </font> and Interim Chief Executive Officer of OptiCare, is the sole     stockholder of OptiCare, PC, the <font color="blue">counterparty</font> to such <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>18       _________________________________________________________________    [65]Table of Contents       If OptiCare’s Managed Vision Care Division Fails to Negotiate Profitable     Capitated Fee Arrangements, it <font color="blue">Could Have A Material Adverse Effect </font>on the     Results of Operations and Financial Condition of the Combined Company</td>
    </tr>
    <tr>
      <td>Under some <font color="blue">managed care</font> contracts, known as “capitation” contracts,     <font color="blue">health care provider</font>s accept a fixed <font color="blue">payment per</font> member per month, whether     or not a person <font color="blue">covered by</font> a <font color="blue">managed care</font> plan receives any services, and     the <font color="blue">health care provider</font> is obligated to provide all <font color="blue">necessary covered</font>     services  to  the  <font color="blue">patients covered under</font> the <font color="blue">agreement</font></td>
    </tr>
    <tr>
      <td>Many of these     contracts pass part of the <font color="blue">financial risk</font> of <font color="blue">providing care from</font> the payer,     ie, an  HMO,  health  insurer, employee welfare plan or self-insured     employer, to the provider</td>
    </tr>
    <tr>
      <td>The growth of <font color="blue">capitation contracts</font> in markets     which  <font color="blue">OptiCare  </font><font color="blue">serves could</font> result in <font color="blue">less certainty with respect</font> to     <font color="blue">profitability</font> and require a <font color="blue">higher level</font> of <font color="blue">actuarial acumen than</font> <font color="blue">OptiCare  </font>   <font color="blue">currently uses</font> to <font color="blue">evaluate such contracts</font></td>
    </tr>
    <tr>
      <td>We do not know whether <font color="blue">OptiCare  </font>   will be able to continue to <font color="blue">negotiate arrangements on</font> a capitated or other     risk-sharing basis that prove to be profitable, or to pass the financial     risks  of  providing  care  to other parties, or to <font color="blue">accurately predict</font>     <font color="blue">utilization</font> or the costs of rendering services</td>
    </tr>
    <tr>
      <td>In addition, changes in     federal or state <font color="blue">regulations</font> of these <font color="blue">contracts may limit</font> OptiCare’s ability     to transfer <font color="blue">financial risk</font>s away from itself</td>
    </tr>
    <tr>
      <td>Any <font color="blue">such developments could</font>     have a material adverse effect on the business, <font color="blue">financial condition</font> and     results of <font color="blue">operations</font> of the <font color="blue">combined company</font> following the mergers</td>
    </tr>
    <tr>
      <td>US Vision’s  Revenues Depend Largely Upon its <font color="blue">Lease Arrangement </font>with     JC Penney Company, Inc</td>
    </tr>
    <tr>
      <td>For the <font color="blue">fiscal year</font> ended January 31, 2005, 96dtta2prca of US Vision’s net     sales were <font color="blue">derived from sales</font> in <font color="blue">optical centers located within</font> department     stores</td>
    </tr>
    <tr>
      <td>For the same period, net sales <font color="blue">attributable</font> to optical centers     located  within  JC Penney stores represented approximately 69dtta3prca of     US Vision’s sales</td>
    </tr>
    <tr>
      <td>US Vision is <font color="blue">indirectly dependent on</font> the <font color="blue">operations</font>     and <font color="blue">financial success</font> of its host department stores</td>
    </tr>
    <tr>
      <td>A decline in the sales,     <font color="blue">customer traffic</font> or <font color="blue">overall financial performance</font> of JC Penney and its     other  host department stores, could have a material adverse effect on     US Vision’s business</td>
    </tr>
    <tr>
      <td>It is anticipated that US Vision <font color="blue">will continue</font> to     <font color="blue">rely upon several host stores</font> for a majority of its <font color="blue">revenues following</font> the     mergers</td>
    </tr>
    <tr>
      <td>However, we <font color="blue">cannot assure</font> you that US Vision will be able to     maintain its <font color="blue">relationships</font> with Sears or its other host stores on favorable     terms, if at all, following the mergers</td>
    </tr>
    <tr>
      <td>US Vision’s <font color="blue">optical centers within</font> JC Penney stores are subject to     a <font color="blue">master lease</font> that expires in <font color="blue">December </font>2007, but either party has the     option to extend the term of the <font color="blue">lease until</font> <font color="blue">December </font>2010</td>
    </tr>
    <tr>
      <td>The <font color="blue">master lease</font>     may be terminated early, but no more than 40 of US Vision’s <font color="blue">JC Penney     </font><font color="blue">optical centers may</font> be closed by JC Penney in any <font color="blue">calendar year</font> for any     reason, excluding any US Vision stores closed by JC Penney as a result     of a temporary or permanent closing of a JC Penney department store</td>
    </tr>
    <tr>
      <td>The lease requires US Vision to pay <font color="blue">additional</font> <font color="blue">license fees</font> to     JC Penney should it <font color="blue">enter into</font> a licensed department <font color="blue">agreement</font> or similar     <font color="blue">arrangement with</font> a <font color="blue">national chain</font> of department stores or large chain of     discount  stores that provides for more favorable terms and <font color="blue">conditions</font>     relating to the amount and payment of <font color="blue">license fees</font></td>
    </tr>
    <tr>
      <td>A substantial change in US Vision’s <font color="blue">relationship with</font> <font color="blue">JC Penney     </font>resulting in the <font color="blue">termination</font> or change of <font color="blue">optical center leases would</font> have a     material adverse effect on US Vision’s business, <font color="blue">financial condition</font>     and/or results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>US Vision’s Revenues Also Depend Upon its <font color="blue">Lease Arrangements </font>with Other     Department Stores</td>
    </tr>
    <tr>
      <td>Many of US Vision’s <font color="blue">retail optical</font> departments located within other     department  stores are subject to <font color="blue">lease arrangements</font> that <font color="blue">permit lease</font>     <font color="blue">termination</font>  on short notice</td>
    </tr>
    <tr>
      <td>There can be no assurance that any lease     between US Vision and a <font color="blue">host store will</font> not be terminated or its terms     <font color="blue">adversely</font> changed</td>
    </tr>
    <tr>
      <td>A substantial change in US Vision’s <font color="blue">relationship with</font>     one or more of its host department stores resulting in the <font color="blue">termination</font> or     change of <font color="blue">optical center leases could</font> have a material adverse effect on its     business, prospects, <font color="blue">financial condition</font> or results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>19       _________________________________________________________________    [66]Table of Contents       US Vision’s Business is <font color="blue">Materially Dependent </font>upon a <font color="blue">Single Laboratory</font></td>
    </tr>
    <tr>
      <td>US Vision finishes all of its <font color="blue">merchandise at</font> its <font color="blue">optical laboratory</font>,     <font color="blue">distribution</font> and <font color="blue">lens grinding <font color="blue">facility</font></font></td>
    </tr>
    <tr>
      <td>An <font color="blue">interruption</font> in <font color="blue">production at</font>     the <font color="blue">facility</font> is likely to have a material adverse effect on the combined     company’s business, <font color="blue">financial condition</font> or results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td><font color="blue">Failure  </font>to  Have  Vision  Care  Professionals  Available  in  or Near     US Vision’s Vision Centers Would Adversely Affect its Ability to Win     Managed Care and Host Store Contracts, and Could Prevent US Vision From     Operating in Some States</td>
    </tr>
    <tr>
      <td>US Vision’s  business  and <font color="blue">marketing strategies emphasize</font> the     <font color="blue">availability</font> of <font color="blue">independent</font> <font color="blue">optometrists</font> in close proximity to its vision     centers</td>
    </tr>
    <tr>
      <td>Accordingly, US Vision has made <font color="blue">arrangements with licensed</font>     <font color="blue">optometrists</font> to <font color="blue">provide eye examination services at</font> or <font color="blue">adjacent</font> to its     <font color="blue">retail locations</font> in those states where it is permitted</td>
    </tr>
    <tr>
      <td>These <font color="blue">independent</font>     <font color="blue">optometrists</font> sublease space and <font color="blue">equipment from</font> US Vision or from the host     store</td>
    </tr>
    <tr>
      <td><font color="blue">While US Vision </font>and the <font color="blue">optometrists</font> do not share in each other’s     revenues, US Vision believes the presence of the <font color="blue">optometrists</font> offering eye     exams at its <font color="blue">stores helps</font> to generate sales, leads to repeat customers and     reinforces the quality and <font color="blue">professional</font>ism of <font color="blue">each store</font></td>
    </tr>
    <tr>
      <td>Any <font color="blue">difficulties</font>     or delays in securing the services of these <font color="blue">professional</font>s could <font color="blue">adversely</font>     affect its business</td>
    </tr>
    <tr>
      <td><font color="blue">Compliance </font>with Section 404 of the Sarbanes-Oxley Act of 2002 is Likely to     be Costly</td>
    </tr>
    <tr>
      <td>Absent an <font color="blue">additional</font> extension from the Securities and Exchange     Commission or change in its <font color="blue">regulations</font>, over the next year, <font color="blue">the Company     </font>will need to document and test its <font color="blue">internal control procedures</font> in order to     satisfy the <font color="blue">requirements</font> of Section 404 of the Sarbanes-Oxley Act of 2002</td>
    </tr>
    <tr>
      <td>This law requires annual <font color="blue">management</font> <font color="blue">assessments</font> of the <font color="blue">effectiveness</font> of our     <font color="blue">internal controls over financial</font> reporting and, commencing with <font color="blue">fiscal year</font>     2007, a report by our <font color="blue">independent</font> auditors addressing these <font color="blue">assessments</font></td>
    </tr>
    <tr>
      <td>Our     efforts to <font color="blue">comply with</font> this law will result in <font color="blue">significant added expense</font> and     a diversion of <font color="blue">management</font> time from strategic <font color="blue">activities</font> to compliance     <font color="blue">activities</font></td>
    </tr>
  </tbody>
</table>